Patents by Inventor Jean-Sebastien Garrigue

Jean-Sebastien Garrigue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110124616
    Abstract: A composition includes at least one fatty acid glycerol ester for use during or after a vitrectomy procedure, the composition being bioresorbable, being injectable in the vitreous cavity, having a density below 1, more preferably between 0.90 and 1, or a density above 1, more preferably between 1 and 1.5; having a surface tension of less than 50 dynes/cm more preferably ranging from 20 and 30 dynes/cm, being not susceptible to emulsify into droplets when injected; method for treating a retinal disorder involving the use of the composition.
    Type: Application
    Filed: November 19, 2010
    Publication date: May 26, 2011
    Applicant: NOVAGALI PHARMA S.A.
    Inventors: Frédéric LALLEMAND, Jean-Sébastien GARRIGUE, Jeffrey HEIER
  • Publication number: 20110118349
    Abstract: A composition for use in treating corneal and conjunctival lesions, includes a prostaglandin F2alpha or analogue, in a therapeutic amount, the composition being in a form suitable for topical application on the ocular surface and is free of deleterious preservative. A method for treating surface ocular conditions in a patient in need thereof, includes administering an effective amount of the composition.
    Type: Application
    Filed: November 19, 2010
    Publication date: May 19, 2011
    Applicant: NOVAGALI PHARMA S.A.
    Inventors: Jean-Sébastien GARRIGUE, Frédéric LALLEMAND, Philippe DAULL, Christophe BAUDOUIN
  • Publication number: 20110021443
    Abstract: Oil-in-water emulsion including a non-steroidal anti-inflammatory drug and a quaternary ammonium halide useful for the prevention and treatment of inflammation in the eye, and process for manufacturing thereof.
    Type: Application
    Filed: July 29, 2010
    Publication date: January 27, 2011
    Applicant: NOVAGALI PHARMA SA
    Inventors: Grégory LAMBERT, Laura RABINOVICH-GUILATT, Frédéric LALLEMAND, Jean-Sébastien GARRIGUE, Betty PHILIPS
  • Publication number: 20090170944
    Abstract: This invention relates to micellar compositions comprising at least one pharmaceutically active substance and a mixture of n-alkyl dimethyl benzyl ammonium chlorides, wherein the mixture comprises more than 30% n-alkyl dimethyl benzyl ammonium chlorides having a chain length superior or equal to C16, wherein the pharmaceutically active substance exhibits an improved stability. In particular, a composition is provided that comprises cetalkonium chloride micelles incorporating the prostaglanding-like therapeutic agent, latanoprost. This invention also relates to ophthalmic compositions containing such micellar compositions and methods of using these ophthalmic compositions for the treatment of eye conditions.
    Type: Application
    Filed: January 2, 2008
    Publication date: July 2, 2009
    Applicant: NOVAGALI PHARMA SA
    Inventors: Gregory Lambert, Frederic Lallemand, Laura Rabinovich-Guilatt, Severine Bague, Jean-Sebastien Garrigue
  • Publication number: 20090169629
    Abstract: This invention relates to micellar compositions comprising at least one pharmaceutically active substance and a mixture of n-alkyl dimethyl benzyl ammonium chlorides, wherein the mixture comprises more than 30% n-alkyl dimethyl benzyl ammonium chlorides having a chain length superior or equal to C16. This invention also relates to ophthalmic compositions containing such micellar compositions and methods of using these ophthalmic compositions for the treatment of eye conditions.
    Type: Application
    Filed: January 2, 2008
    Publication date: July 2, 2009
    Applicant: NOVAGALI PHARMA SA
    Inventors: Gregory LAMBERT, Frederic LALLEMAND, Laura RABINOVICH-GUILATT, Severine BAGUE, Jean-Sebastien GARRIGUE
  • Publication number: 20090018057
    Abstract: Oil-in-water emulsion comprising a non-steroidal anti-inflammatory drug and a quaternary ammonium halide useful for the prevention and treatment of inflammation in the eye, and process for manufacturing thereof.
    Type: Application
    Filed: July 9, 2007
    Publication date: January 15, 2009
    Inventors: Gregory LAMBERT, Laura RABINOVICH-GUILATT, Frederic LALLEMAND, Jean-Sebastien GARRIGUE
  • Publication number: 20070248645
    Abstract: An ophthalmic oil-in-water type emulsion, which includes colloid particles having an oily core surrounded by an interfacial film, the emulsion including at least one cationic agent, at least one no ionic surfactant, the emulsion having a positive zeta potential and meeting zeta potential stability Test A requirements. Process for making the emulsions. Delivery device selected from the group including lenses, ocular patch, implant, insert, the device containing an emulsion according to the invention.
    Type: Application
    Filed: October 10, 2005
    Publication date: October 25, 2007
    Inventors: Severine Bague, Betty Philips, Laura Rabinovich-Guilatt, Gregory Lambert, Jean-Sebastien Garrigue
  • Publication number: 20060292186
    Abstract: A pharmaceutical composition in a form of an anhydrous self-nanoemulsifying oily formulation comprising: one or more therapeutic agent(s) which have low solubility in water or are water-insoluble, vitamin E, one co-solvent selected from propylene glycol and ethanol and mixture thereof one surfactant selected from tyloxapol and from mixture of tyloxapol and TPGS, and optionally, a bioenhancer.
    Type: Application
    Filed: August 27, 2004
    Publication date: December 28, 2006
    Applicant: Novagali Pharma SA
    Inventors: Jean-Sebastien Garrigue, Gregory Lambert, Alain Razafindratsita, Simon Benita, Shicheng Yang, Neslihan Gursoy
  • Publication number: 20060100288
    Abstract: A well tolerated oil-in-water emulsion useful as a delivery vehicle of hydrophobic ingredients such as pharmaceutical drugs, wherein the emulsion particles have a net positive charge and comprises 0.001 to 0.1% of a cationic agent, 0 to 1% of a non ionic surfactant and 0 to 0.5% of an anionic surfactant.
    Type: Application
    Filed: November 18, 2004
    Publication date: May 11, 2006
    Inventors: Severine Bague, Betty Philips, Jean-Sebastien Garrigue, Laura Rabinovich-Guilatt, Gregory Lambert
  • Publication number: 20050232952
    Abstract: A pharmaceutical composition in a form of a self-microemulsifying drug delivery system comprising: one or more therapeutic agent(s) which have low solubility in water or are water-insoluble, vitamin E, one co-solvent selected from propylene glycol and ethanol, one or more bile salts, TPGS, and one further surfactant selected from Tyloxapol and polyoxyl hydrogenated castor oil.
    Type: Application
    Filed: February 28, 2003
    Publication date: October 20, 2005
    Inventors: Gregory Lambert, Alain Razafindratsita, Jean-Sebastien Garrigue, Shicheng Yang, Neslihan Gursoy, Simon Benita